Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Harrell W Chesson

11PUBLICATIONS
24CO-AUTHORS
Major global burdens of diseasePacific Peoples health promotionEpidemiological modellingPreventative health careDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Nov 25, 2025
Estimating Productivity Losses per HIV Infection due to Premature HIV Mortality in the United States.

Md Hafizul Islam, Harrell W Chesson, Ruiguang Song

|Nov 17, 2025
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.

Jean-François Laprise, Harrell W Chesson, Lauri E Markowitz

|Apr 18, 2025
The Influence of Epidemiologic Context on the Success of Partner Notification Programs: Analysis of Gonorrhea Transmission Dynamics.

Minttu M Rönn, Harrell W Chesson, Yonatan H Grad

|Mar 05, 2025
Strong Herd Effects of Human Papillomavirus Vaccination.

Harrell W Chesson, Lauri E Markowitz

|Mar 03, 2025
An Updated Spreadsheet Tool to Estimate the Health and Economic Benefits of Sexually Transmitted Infection and HIV Prevention Activities.

Harrell W Chesson, Austin M Williams, Bahareh Ansari

|Nov 25, 2024
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States.

Jean-François Laprise, Harrell W Chesson, Lauri E Markowitz

Pageof 2

Frequent Collaborators

2 joint publications

Eli S Rosenberg

2 joint publications

Lauri E Markowitz

2 joint publications

Jean-François Laprise

1 joint publications

Kevin M Weiss

1 joint publications

Jeb S Jones

1 joint publications

Kimberly Workowski

1 joint publications

Ashleigh Tuite

1 joint publications

Samuel M Jenness

1 joint publications

Md Hafizul Islam

1 joint publications

Zanetta Gant

Frequent Collaborators

2 joint publications

Eli S Rosenberg

2 joint publications

Lauri E Markowitz

2 joint publications

Jean-François Laprise

1 joint publications

Kevin M Weiss

Top Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on : Oct 06, 2022

2.8K
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on : Mar 08, 2012

12.9K
Quantitative Examination of Antibiotic Susceptibility of <em>Neisseria gonorrhoeae</em> Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of <em>Neisseria gonorrhoeae</em> Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on : Feb 08, 2019

8.6K
See more related videos

Top Related Videos

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
06:07

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on : Oct 06, 2022

2.8K
Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-&gamma; Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on : Mar 08, 2012

12.9K
Quantitative Examination of Antibiotic Susceptibility of <em>Neisseria gonorrhoeae</em> Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining
08:04

Quantitative Examination of Antibiotic Susceptibility of <em>Neisseria gonorrhoeae</em> Aggregates Using ATP-utilization Commercial Assays and Live/Dead Staining

Published on : Feb 08, 2019

8.6K
See more related videos